Mechanisms of error-free cell division after whole-genome doubling
全基因组加倍后无差错细胞分裂的机制
基本信息
- 批准号:9750286
- 负责人:
- 金额:$ 7.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2019-11-30
- 项目状态:已结题
- 来源:
- 关键词:AneuploidyBindingBiosensorBuffersCCNE1 geneCancer cell lineCell SurvivalCell divisionCellsCentrosomeChromosomal InstabilityChromosome SegregationChromosomesComplexDataDiploid CellsDiploidyEnsureEssential GenesEventEvolutionFluorescence Resonance Energy TransferFrequenciesGeneticGenome StabilityGoalsHumanHuman Cell LineImmunofluorescence ImmunologicIn VitroIndividualKinetochoresKnowledgeMalignant NeoplasmsMicrotubulesMissense MutationMitosisMitoticMitotic spindleMolecularMutationOutcomePathway interactionsPhosphorylationPhosphorylation SitePloidiesPolyploid CellsProtein phosphataseRecurrenceRegulationResearchResolutionRouteSignal TransductionStressSubstrate SpecificityTP53 geneTestingTetraploidyTherapeuticTimeWorkbasecancer cellcellular imagingchromosome losschromosome missegregationcostexperiencefitnesshigh resolution imagingimprovedin vivoinnovationlive cell imagingmutantneoplastic cellphosphoproteomicsprotein phosphatase 2A regulatory subunit 65 kDascaffoldtherapeutic targettumortumorigenesiswhole genome
项目摘要
PROJECT SUMMARY
A prevalent route to aneuploidy for diploid cells is the occurrence of a Whole-Genome Doubling (WGD)
followed by chromosome loss. WGD buffers against deleterious effects of changes in essential genes during
tumor cell evolution. However, WGD also results in a doubling of centrosome content, which can be
deleterious during mitosis. This is because each of the centrosomes nucleates microtubules, resulting in a
multipolar spindle. There are two potential outcomes when this happens: cells can initiate a multipolar division,
which is lethal, or they can re-organize the multipolar spindle into a bipolar spindle by clustering the extra
centrosomes. The latter outcome allows for bipolar cell division and survival, but with an increased rate of
chromosome segregation errors. After WGD, normal untransformed human cells experience both cell division
outcomes with approximately equal frequency. Cancer cell lines, by contrast, are generally more proficient at
clustering extra centrosomes, but how this occurs is not known. The long-term goal of this work, therefore, is to
define mechanisms that allow cells to survive mitosis after WGD. The overall objective of this proposal is to
define how cancer-associated mutations and deletions in protein phosphatase 2A (PP2A) alter mitosis after
WGD. The central hypothesis is that PP2A inactivation increases the viability of cells after WGD through
enhanced centrosome clustering and reduction in chromosome segregation errors. This hypothesis is based
on studies of a prevalent mis-sense mutation in PP2A-A, a core component of heterotrimeric PP2A complexes.
The rationale for the proposed research is that knowledge of how cancer cells mitigate the stress associated
with WGD, and more specifically, how recurrent PP2A-A mutations change mitosis, could potentially be used
to therapeutically target those pathways in cancer cells. Our objective will be realized by the following two
aims: (1) Identify how PP2A controls centrosome clustering. Phosphorylation of NuMA and TPX2, two
regulators of spindle assembly, is altered by PP2A-A mutation. Complementary in vivo and in vitro approaches
will be used to determine how this impacts centrosome clustering after WGD. (2) Identify how PP2A controls
the fidelity of chromosome segregation. High-resolution live-cell imaging, FRET-based phosphorylation
biosensors, and quantitative immunofluorescence of endogenous kinetochore substrates will be used to test
the hypothesis that PP2A-A mutation reduces chromosome segregation errors through altered phospho-
signaling at kinetochores. The long-term impact of PP2A-A mutation on genome stability in cells that
experience WGD will also be determined. Successful completion of this work will establish how human cancers
`fine-tune' phosphorylation to ensure proliferation after WGD. This knowledge could inform on strategies to
target tumor cells with ploidy changes or supernumerary centrosomes.
!
!
项目摘要
二倍体细胞非整倍体的一个普遍途径是发生全基因组加倍(WGD)
随后染色体丢失。WGD缓冲剂对在生长期间必需基因变化的有害影响
肿瘤细胞进化然而,WGD也导致中心体含量加倍,这可能是因为
在有丝分裂期间有害。这是因为每个中心体都使微管成核,从而导致微管的分裂。
多极纺锤体当这种情况发生时,有两种潜在的结果:细胞可以启动多极分裂,
这是致命的,或者它们可以通过聚集额外的
中心体后一种结果允许双极细胞分裂和存活,但增加了细胞分裂的速率。
染色体分离错误在WGD后,正常的未转化的人细胞经历细胞分裂和细胞分裂。
频率大致相等。相比之下,癌细胞系通常更擅长于
聚集额外的中心体,但这是如何发生的还不清楚。这项工作的长期目标是,
定义允许细胞在WGD后在有丝分裂中存活的机制。本建议的总体目标是
定义蛋白磷酸酶2A(PP2A)中的癌症相关突变和缺失如何改变有丝分裂,
WGD。中心假设是PP2A失活通过以下途径增加WGD后细胞的活力:
增强中心体聚类和减少染色体分离错误。这个假设是基于
关于PP2A-A中普遍存在的错义突变的研究,PP2A-A是异源三聚体PP2A复合物的核心成分。
这项研究的基本原理是,了解癌细胞如何减轻与癌症相关的压力,
更具体地说,PP2A-A突变如何改变有丝分裂,
来治疗癌细胞中的这些通路。我们的目标将通过以下两个方面来实现
目的:(1)研究PP2A对中心体成簇的调控作用。NuMA和TPX2的磷酸化,两个
纺锤体组装的调节因子,通过PP2A-A突变而改变。互补的体内和体外方法
将用于确定这如何影响WGD后的中心体聚类。(2)了解PP2A如何控制
染色体分离的精确性。高分辨率活细胞成像,FRET磷酸化
生物传感器和内源性动粒底物的定量免疫荧光将用于测试
PP2A-A突变通过改变磷酸化水平来减少染色体分离错误的假设,
在着丝粒上发出信号PP2A-A突变对细胞基因组稳定性的长期影响,
还将确定WGD的经验。这项工作的成功完成将建立人类癌症如何
"微调"磷酸化以确保WGD后的增殖。这些知识可以为战略提供信息,
靶向具有倍性改变或额外中心体的肿瘤细胞。
!
!
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Prasad V Jallepalli其他文献
Prasad V Jallepalli的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Prasad V Jallepalli', 18)}}的其他基金
Regulation of Chromosome Segregation in Human Cells
人体细胞染色体分离的调控
- 批准号:
7426439 - 财政年份:2005
- 资助金额:
$ 7.62万 - 项目类别:
Regulation of Chromosome Segregation in Human Cells
人体细胞染色体分离的调控
- 批准号:
8469523 - 财政年份:2005
- 资助金额:
$ 7.62万 - 项目类别:
Regulation of Chromosome Segregation in Human Cells
人体细胞染色体分离的调控
- 批准号:
8697767 - 财政年份:2005
- 资助金额:
$ 7.62万 - 项目类别:
Regulation of Chromosome Segregation in Human Cells
人体细胞染色体分离的调控
- 批准号:
8075456 - 财政年份:2005
- 资助金额:
$ 7.62万 - 项目类别:
Regulation of Chromosome Segregation in Human Cells
人体细胞染色体分离的调控
- 批准号:
10180979 - 财政年份:2005
- 资助金额:
$ 7.62万 - 项目类别:
Regulation of Chromosome Segregation in Human Cells
人体细胞染色体分离的调控
- 批准号:
6918125 - 财政年份:2005
- 资助金额:
$ 7.62万 - 项目类别:
Regulation of Chromosome Segregation in Human Cells
人体细胞染色体分离的调控
- 批准号:
7886056 - 财政年份:2005
- 资助金额:
$ 7.62万 - 项目类别:
Regulation of Chromosome Segregation in Human Cells
人体细胞染色体分离的调控
- 批准号:
7623610 - 财政年份:2005
- 资助金额:
$ 7.62万 - 项目类别:
Regulation of Chromosome Segregation in Human Cells
人体细胞染色体分离的调控
- 批准号:
8286240 - 财政年份:2005
- 资助金额:
$ 7.62万 - 项目类别:
Regulation of Chromosome Segregation in Human Cells
人体细胞染色体分离的调控
- 批准号:
7247247 - 财政年份:2005
- 资助金额:
$ 7.62万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 7.62万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 7.62万 - 项目类别:
Continuing Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 7.62万 - 项目类别:
Standard Grant
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 7.62万 - 项目类别:
Research Grant
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 7.62万 - 项目类别:
Fellowship
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 7.62万 - 项目类别:
Discovery Projects
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 7.62万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 7.62万 - 项目类别:
Research Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 7.62万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 7.62万 - 项目类别:
Discovery Projects